BACKGROUND AND OBJECTIVES: Alteration of homotypic cell-cell adhesion has been suggested to play an important role in tumor progression. The present study examined the relationship between neural cell adhesion molecules and state of proliferation of small cell lung cancer (SCLC) cells. METHODS: Seventeen surgically resected specimens of SCLC were immunohistochemically examined, by using monoclonal antibodies against neural cell adhesion molecule (NCAM) and its polysialic acid side chains, and L1 cell adhesion molecule (L1-CAM). Ki-67 labeling indices were also determined immunohistochemically. RESULTS: All patients were positive for L1-CAM. Fifteen patients (88.2%) were positive for NCAM. Among the fifteen patients, nine (60.0%) were positive for NCAM PSA side chain. The probability of survival of the NCAM without PSA side chain group was significantly higher than that of the NCAM with PSA side chain group (log-rank test; P = 0.500). CONCLUSIONS: The expression of NCAM with PSA side chains might be a prognostic factor and NCAM a marker for SCLC. L1-CAM may be synthesized independent of state of proliferation of individual tumor cell and may affect clinical feature of SCLC. Copyright 2001 Wiley-Liss, Inc.
BACKGROUND AND OBJECTIVES: Alteration of homotypic cell-cell adhesion has been suggested to play an important role in tumor progression. The present study examined the relationship between neural cell adhesion molecules and state of proliferation of small cell lung cancer (SCLC) cells. METHODS: Seventeen surgically resected specimens of SCLC were immunohistochemically examined, by using monoclonal antibodies against neural cell adhesion molecule (NCAM) and its polysialic acid side chains, and L1 cell adhesion molecule (L1-CAM). Ki-67 labeling indices were also determined immunohistochemically. RESULTS: All patients were positive for L1-CAM. Fifteen patients (88.2%) were positive for NCAM. Among the fifteen patients, nine (60.0%) were positive for NCAM PSA side chain. The probability of survival of the NCAM without PSA side chain group was significantly higher than that of the NCAM with PSA side chain group (log-rank test; P = 0.500). CONCLUSIONS: The expression of NCAM with PSA side chains might be a prognostic factor and NCAM a marker for SCLC. L1-CAM may be synthesized independent of state of proliferation of individual tumor cell and may affect clinical feature of SCLC. Copyright 2001 Wiley-Liss, Inc.
Authors: Rui Liu; Yu Shi; Hai Jie Yang; Lei Wang; Si Zhang; Yin Yan Xia; Jing Lin Jack Wong; Zhi Wei Feng Journal: J Biol Chem Date: 2011-05-31 Impact factor: 5.157
Authors: Jussuf T Kaifi; Ulrich Zinnkann; Emre F Yekebas; Paulus G Schurr; Uta Reichelt; Robin Wachowiak; Henning C Fiegel; Susann Petri; Melitta Schachner; Jakob R Izbicki Journal: World J Gastroenterol Date: 2006-01-07 Impact factor: 5.742
Authors: S Sowparani; P Mahalakshmi; J Pushpa Sweety; Arul Prakash Francis; U M Dhanalekshmi; N Selvasudha Journal: Mol Neurobiol Date: 2022-07-12 Impact factor: 5.682
Authors: Penelope M Drake; Christina M Stock; Jay K Nathan; Phung Gip; Kevin P K Golden; Birgit Weinhold; Rita Gerardy-Schahn; Carolyn R Bertozzi Journal: Proc Natl Acad Sci U S A Date: 2009-07-08 Impact factor: 11.205
Authors: Verena Tischler; Marco Pfeifer; Silke Hausladen; Uwe Schirmer; Anne-Katrine Bonde; Glen Kristiansen; Martin L Sos; Walter Weder; Holger Moch; Peter Altevogt; Alex Soltermann Journal: Mol Cancer Date: 2011-10-10 Impact factor: 27.401
Authors: Penelope M Drake; Jay K Nathan; Christina M Stock; Pamela V Chang; Marcus O Muench; Daisuke Nakata; J Rachel Reader; Phung Gip; Kevin P K Golden; Birgit Weinhold; Rita Gerardy-Schahn; Frederic A Troy; Carolyn R Bertozzi Journal: J Immunol Date: 2008-11-15 Impact factor: 5.422